Chantal Mathieu

32PUBLICATIONS

106CO-AUTHORS

Autonomic nervous systemMultimorbidityGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Metabolic medicine

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Jun 08, 2026

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

|Nov 19, 2025

System Failure in Type 1 Diabetes: What Stakeholders Need to Know to Expedite Therapeutic Options.

Colin M Dayan, Chantal Mathieu, Douglas Lowenstein

|Nov 06, 2025

Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab.

Chantal Mathieu, Emily K Sims, Lucienne Chatenoud

|Jul 30, 2025

The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.

Carmella Evans-Molina, Yuval Dor, Åke Lernmark

|Jul 30, 2025

The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.

Carmella Evans-Molina, Yuval Dor, Åke Lernmark

|Jul 30, 2025

The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.

Carmella Evans-Molina, Yuval Dor, Åke Lernmark

Pageof 6

Frequent Collaborators

5 joint publications

Roman Vangoitsenhoven

Paresh Dandona

Stephen S Rich

John B Buse

Eddie A James

Carmella Evans-Molina

Emily Sims

Geltrude Mingrone

Apostolos Tsapas

Roberto Mallone

Frequent Collaborators

5 joint publications

Roman Vangoitsenhoven

4 joint publications

Paresh Dandona

4 joint publications

Stephen S Rich

4 joint publications

John B Buse